JSPR   $21.92  0.23% Market Open

Jasper Therapeutics Inc
Total Cash 106.82M
totalCashPerShare 7.072
EBITDA -67.01M
Total Debt 2.32M
quickRatio 10.635
currentRatio 10.795
Total Revenue
debtToEquity 2.309
Revenue/Share
ROA -0.35779
ROE -0.59317
grossProfits
freeCashflow -34.78M
operatingCashflow -55.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 253.49M
forwardPE -5.7524276
floatShares 9.39M
sharesOutstanding 15.11M
sharesShort 1.81M
sharesShortPriorMonth 1.93M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.98%
Short Ratio help_outline 5.51%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 6.641
Price To Book help_outline 3.57
earningsQuarterlyGrowth
netIncomeToCommon -62.44M
trailingEps -5.40%
forwardEps -4.12%
enterpriseToEbitda -3.78
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.07 3Q 2024
institutionsCount 106
lastUpdated Nov. 7, 2024, 5:18 a.m.